US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company’s bird flu vaccine, as fears of a new ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The H5N1 virus is common in wild birds and other animals. While it has not conclusively been found to spread from person to ...

The version of the virus spreading in North America right now has led to only a few serious cases, but concerns have been ...

The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the ...

The United States government has allocated $590 million to Moderna to develop a vaccine for avian influenza, part of an ...

Moderna Inc. was awarded an additional $590 million from the US government to help the company develop a vaccine aimed at ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Shares of Moderna (NASDAQ:MRNA) jumped 5% following reports that it had been awarded $590 million for the development of a ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

Funding will also support the expansion of clinical studies for up to five additional subtypes of pandemic influenza ...